Lung Cancer
From the Journals
Adding bevacizumab improves PFS in extensive SCLC
Phase III study results show that combining bevacizumab with chemotherapy improves PFS in SCLC.
From the Journals
Lung cancer screening a challenge to implement
Screening for lung cancer resulted in few cancers detected but more than half of patients needing follow-up.
Conference Coverage
Nivolumab effective in PD-L1–deficient lung cancers
A detailed analysis of nivolumab’s performance in a pivotal trial with non–small cell lung cancer patients showed similar efficacy to docetaxel...
From the Journals
Cardiac events after NSCLC radiotherapy occur early
Cardiac events are “relatively common,” affecting 23% of patients, and occur earlier than previously thought following radiotherapy for non–small-...
From the Journals
Deferring RT for brain mets in EGFR-mutated NSCLC shortens survival
Deferring radiotherapy to administer epidermal growth factor receptor tyrosine kinase inhibitors first doesn’t prolong overall survival, it...
Conference Coverage
Age and disease stage predict long-term survival in elderly lung cancer patients
Although certain medical factors predict long-term survival in patients over age 65 with lung cancer, advanced age and disease stage are...
From the Journals
Survey finds link between e-cigarette use and high-risk behaviors
High school students who use electronic vapor products, whether alone or in combination with cigarette smoking, are more likely to engage in...
From the Journals
Sleeve lobectomy appears better than pneumonectomy for NSCLC
Sleeve lobectomy for NSCLC may lead to higher rates of overall and disease-free survival vs. pneumonectomy.
Conference Coverage
PD-L1 testing in NSCLC patients shows high concordance
VIENNA - Several different tests for PD-L1 levels in tumor cells of patients with metastatic non-small cell lung cancer showed high concordance...
From the Journals
In NSCLC, delayed chemo yields survival benefit comparable to early chemo
In patients with non–small-cell lung cancer for whom adjuvant chemotherapy must be delayed for as long as 18 weeks, mortality outcomes are no...